Skip to main content
  • OAC ALONE fails to establish noninferiority of oral anticoagulants alone to OAC plus antiplatelet beyond 1 year after coronary stenting

    SAN DIEGO — The use of oral anticoagulants (OAC) alone failed to establish noninferiority to anticoagulants plus single antiplatelet therapy (SAPT) beyond 1 year after coronary stenting in patients with atrial fibrillation and stable coronary artery disease, according to findings presented Monday at the Transcatheter Cardiovascular Therapeutics (TCT) conference.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details